# Algeta

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/algeta

- Industry: Pharmaceuticals
- Headquarters: Oslo, Norway
- Website: www.algeta.com
- Total disclosed funding: $28M
- Latest round: Series A (Jun 1, 2005)
- Investors on record: 6

## About

Founded in 1997 and based in Norway, Algeta is an oncology company that engages in the development of targeted therapies for patients with cancer, based on its alpha-pharmaceutical platform.

## Funding rounds

- Series A, Jun 1, 2005, $28M — HealthCap, SR One, Incitia Ventures, NorgesInvestor, Marlin Verdi AS, Advent Life Sciences

## Investors

- HealthCap — Series A
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A
- Incitia Ventures (https://capitalatlas.ai/funds/incitia-ventures) — Series A
- NorgesInvestor (https://capitalatlas.ai/funds/norgesinvestor) — Series A
- Marlin Verdi AS — Series A
- Advent Life Sciences (https://capitalatlas.ai/funds/advent-life-sciences) — Series A